CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing information about a medication that is
undergoing a large clinical study before possible approval for
widespread use. Which characteristic best describes a phase III
clinical trial?
A. It primarily evaluates medication safety in healthy
volunteers.
B. It compares the medication with standard therapy in a large
population of patients.
C. It determines the medication's chemical structure and
stability.
D. It monitors adverse events after the medication has been
marketed.
Correct Answer: B
Rationale:
Phase III clinical trials evaluate effectiveness and safety in a
large population of patients with the target condition and often
compare the new medication with current standard therapy.
These studies provide critical information for regulatory review.
Phase I trials primarily assess safety and dosage in healthy
volunteers or selected participants. Chemical characterization
occurs during preclinical development. Post-marketing
surveillance occurs during phase IV after regulatory approval.
,Question 2
A nurse explains to a patient that a prescribed medication acts
by binding to a specific receptor on target cells. Which concept
is the nurse describing?
A. Drug receptor interaction
B. Renal elimination
C. Drug metabolism
D. Drug incompatibility
Correct Answer: A
Rationale:
Many medications produce their effects by binding to specific
receptors, triggering or blocking cellular responses. This
interaction is a key pharmacodynamic principle. Renal
elimination refers to drug excretion by the kidneys. Drug
metabolism involves enzymatic conversion, usually in the liver.
Drug incompatibility refers to undesirable physical or chemical
interactions between medications.
Question 3
A patient asks why two medications used to treat the same
condition require different doses. Which response by the nurse
is most accurate?
A. Every medication has identical potency.
, B. Dose differences may reflect variations in potency and
pharmacokinetic properties.
C. Lower doses always produce stronger therapeutic effects.
D. Medication doses are selected randomly during
development.
Correct Answer: B
Rationale:
Different medications vary in potency, absorption, distribution,
metabolism, elimination, and receptor affinity. Therefore,
effective doses differ among medications. Potency does not
necessarily predict clinical effectiveness. Lower doses are not
always more effective, and medication dosing is based on
scientific evidence rather than chance.
Question 4
A nurse administers an analgesic and notes that the patient's
pain decreases within 30 minutes. This observation best
demonstrates which principle?
A. Therapeutic drug response
B. Drug contamination
C. Medication incompatibility
D. Drug diversion